Lipocine Inc. (LPCN)
LPCNNASDAQ-CMBiotechnology: Pharmaceutical Preparations
$1.69
+0.0900 (+5.62%) today
Closed, Nov 9, 4:00 PM ET
- Market cap
- $19.05m
- P/E
- –
- EPS, last 4 quarters
- $-1.28
- Dividend yield
- –
- Day range
- –
- 52-week range
- $1.36 to $12.37
- Average volume
- 2.21m
- Previous close
- $1.60
Analysts
1 coveringHold0 buy, 1 hold, 0 sell
Targets a year out average $4.00, +136.7% from here
Earnings
next estimate $-0.3300Next report
Dec 2025
+43.3%
Mar 2026
-5.9%
Jun 2026
+31.9%
Sep 2026
+79.5%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $115.0k | $1.15m | $119.0k | $190.0k |
| Gross profit | $115.0k | $1.15m | $119.0k | $190.0k |
| Operating income | -$3.36m | -$2.52m | -$3.85m | -$2.84m |
| Net income | -$3.19m | -$2.37m | -$3.67m | -$2.62m |
Last four quarters: revenue $1.57m, margin -755.4%, free cash flow –
News
8 latest- Lipocine Inc. Reports Third Quarter of 2026 Financial Results and Initiates Phase 3 BLOOM StudyFintel · 4 days ago
- Ardelyx (ARDX) Reports Break-Even Earnings for Q3Zacks · 6 days ago
- Weekly Buzz: RHHBY, NVS, PFE Win FDA Nod; CRBU Scales Back; PCVX, ABBV Report Positive Trial Data RTTNews · Oct 9, 2026
- Here's Why You Should Add LPCN Stock to Your Portfolio NowZacks · Oct 8, 2026
- Lipocine Jumps On TLANDO's Health Canada Approval For Testosterone Replacement Therapy RTTNews · Oct 7, 2026
- Monday 10/5 Insider Buying Report: LPCN, CSWC BNK Invest · Oct 5, 2026
- Lipocine (LPCN) Upgraded to Buy: What Does It Mean for the Stock?Zacks · Sep 23, 2026
- Lipocine (LPCN) Reports Q1 Loss, Beats Revenue EstimatesZacks · May 7, 2026
The company
Lipocine is a biopharmaceutical company developing oral therapeutics using its proprietary drug-delivery technology platform. The Company advances product candidates addressing significant unmet medical needs and explores partnerships to support their development and commercialization.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- lipocine.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.